Vaishali Pharma Limited

NSEI:VAISHALI Stock Report

Market Cap: ₹2.4b

Vaishali Pharma Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Vaishali Pharma.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals earnings growth18.2%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

A Piece Of The Puzzle Missing From Vaishali Pharma Limited's (NSE:VAISHALI) 27% Share Price Climb

Sep 13
A Piece Of The Puzzle Missing From Vaishali Pharma Limited's (NSE:VAISHALI) 27% Share Price Climb

The Market Lifts Vaishali Pharma Limited (NSE:VAISHALI) Shares 26% But It Can Do More

Jul 05
The Market Lifts Vaishali Pharma Limited (NSE:VAISHALI) Shares 26% But It Can Do More

Here's Why Vaishali Pharma (NSE:VAISHALI) Has Caught The Eye Of Investors

Jan 17
Here's Why Vaishali Pharma (NSE:VAISHALI) Has Caught The Eye Of Investors

Vaishali Pharma Limited's (NSE:VAISHALI) Shares Leap 30% Yet They're Still Not Telling The Full Story

Dec 18
Vaishali Pharma Limited's (NSE:VAISHALI) Shares Leap 30% Yet They're Still Not Telling The Full Story

Is Vaishali Pharma (NSE:VAISHALI) A Risky Investment?

Dec 11
Is Vaishali Pharma (NSE:VAISHALI) A Risky Investment?

We Ran A Stock Scan For Earnings Growth And Vaishali Pharma (NSE:VAISHALI) Passed With Ease

Oct 04
We Ran A Stock Scan For Earnings Growth And Vaishali Pharma (NSE:VAISHALI) Passed With Ease

With EPS Growth And More, Vaishali Pharma (NSE:VAISHALI) Makes An Interesting Case

Feb 04
With EPS Growth And More, Vaishali Pharma (NSE:VAISHALI) Makes An Interesting Case

Vaishali Pharma (NSE:VAISHALI) Seems To Use Debt Quite Sensibly

Dec 10
Vaishali Pharma (NSE:VAISHALI) Seems To Use Debt Quite Sensibly

We Ran A Stock Scan For Earnings Growth And Vaishali Pharma (NSE:VAISHALI) Passed With Ease

Aug 20
We Ran A Stock Scan For Earnings Growth And Vaishali Pharma (NSE:VAISHALI) Passed With Ease

Should You Be Adding Vaishali Pharma (NSE:VAISHALI) To Your Watchlist Today?

May 19
Should You Be Adding Vaishali Pharma (NSE:VAISHALI) To Your Watchlist Today?

These 4 Measures Indicate That Vaishali Pharma (NSE:VAISHALI) Is Using Debt Reasonably Well

Feb 10
These 4 Measures Indicate That Vaishali Pharma (NSE:VAISHALI) Is Using Debt Reasonably Well

A Look At The Intrinsic Value Of Vaishali Pharma Limited (NSE:VAISHALI)

Aug 17
A Look At The Intrinsic Value Of Vaishali Pharma Limited (NSE:VAISHALI)

A Look At The Fair Value Of Vaishali Pharma Limited (NSE:VAISHALI)

May 17
A Look At The Fair Value Of Vaishali Pharma Limited (NSE:VAISHALI)

Are Vaishali Pharma Limited's (NSE:VAISHALI) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

Mar 17
Are Vaishali Pharma Limited's (NSE:VAISHALI) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

Calculating The Fair Value Of Vaishali Pharma Limited (NSE:VAISHALI)

Feb 15
Calculating The Fair Value Of Vaishali Pharma Limited (NSE:VAISHALI)

Does Vaishali Pharma (NSE:VAISHALI) Have A Healthy Balance Sheet?

Jan 19
Does Vaishali Pharma (NSE:VAISHALI) Have A Healthy Balance Sheet?

Are Vaishali Pharma Limited's (NSE:VAISHALI) Mixed Financials Driving The Negative Sentiment?

Nov 23
Are Vaishali Pharma Limited's (NSE:VAISHALI) Mixed Financials Driving The Negative Sentiment?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Vaishali Pharma has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

NSEI:VAISHALI - Analysts future estimates and past financials data (INR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/20249098N/AN/AN/A
3/31/2024863778N/A
12/31/202380158N/AN/AN/A
9/30/202372364-16-13N/A
6/30/202372967N/AN/AN/A
3/31/202369766811N/A
12/31/202268864N/AN/AN/A
9/30/202271053-11-4N/A
6/30/202277747N/AN/AN/A
3/31/202275840513N/A
12/31/202169324N/AN/AN/A
9/30/2021683254952N/A
6/30/202158519N/AN/AN/A
3/31/2021538101920N/A
12/31/202056017N/AN/AN/A
9/30/202045122727N/A
6/30/20204550N/AN/AN/A
3/31/202060103232N/A
12/31/201966711N/AN/AN/A
9/30/201984010N/AN/AN/A
6/30/20198356N/AN/AN/A
3/31/201975174043N/A
12/31/20186988N/AN/AN/A
9/30/20186479N/AN/AN/A
6/30/20186638N/AN/AN/A
3/31/20186788N/A-95N/A
3/31/20176407N/A5N/A
3/31/20166670N/A46N/A
3/31/20159462N/A-37N/A
3/31/20141,2073N/A-70N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if VAISHALI's forecast earnings growth is above the savings rate (6.7%).

Earnings vs Market: Insufficient data to determine if VAISHALI's earnings are forecast to grow faster than the Indian market

High Growth Earnings: Insufficient data to determine if VAISHALI's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if VAISHALI's revenue is forecast to grow faster than the Indian market.

High Growth Revenue: Insufficient data to determine if VAISHALI's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if VAISHALI's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y